Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Global Multiple Myeloma Market: New Playground for Healthcare - Research and Markets

Research and Markets
Posted on: 19 Aug 16

Research and Markets has announced the addition of the "Global Multiple Myeloma Market: Industry Analysis & Outlook (2016-2030)" report to their offering.

Multiple Myeloma is a type of blood cancer. Large numbers of abnormal plasma cells gather in bone marrow and stop it from producing an important part of immune system. It is caused by malignant plasma cells. Multiple myeloma is accompanied with several risks like low blood counts, bone and calcium problems, infections, kidney problems and nervous system symptoms. Multiple myeloma is a relatively uncommon cancer where the plasma cells which fight infections become malignant. It is the cancer that begins in the blood's plasma cells, a type of white blood cell that is made in the bone marrow.

Being an uncommon disease its cure was also negligible in presence and it was used to be considered as non-treatable disease but the recent efforts by several companies have shown development. Hopes have arrived with the approval of Darzalex which was a much awaited product and has shown positive results in the trials. Many other products are in the pipeline and will arrive after some time. There is much space in the multiple myeloma market for the competitors now but with many products in the pipeline the, market can see lot of competition in the future.

The demand for market will be driven by increased penetration of cancer drugs, increase in ageing population, rising obese population and increase in healthcare expenditure. Some of the noteworthy trends and developments of this industry are upcoming new innovative products in the market, trend of combination therapies, and chance of new players. However, the expansion of global multiple myeloma market is hindered by high price and legal regulations.

Key Topics Covered:

1. Blood Cancer: An Introduction

2. Multiple Myeloma

3. Multiple Myeloma Market Analysis

4. Regional Markets

5. Market Dynamics

6. Competitive Landscape

7. Key Product Analysis

8. Company Profiles

Companies Mentioned:

  • Johnson & Johnson
  • Novartis
  • Roche Holding
  • Sanofi

For more information about this report visit

Related Topics: Hematology

View source version on

Business Wire

Last updated on: 19/08/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.